UnknownNot Applicable

Microwave Ablation in Pulmonary Malignancies

19 participantsStarted 2020-07-15

Plain-language summary

Lung cancer remains to be an important global issue as it is the leading cause of cancer\_ related mortality for both men and women worldwide .Since more than two thirds of cases are diagnosed at an advanced stage,the survival rate of lung cancer is one of the lowest among all cancers.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patient has good compliance and sign the informed consent. * patient with lung cancer who lost the opportunity of surgical resection. * patient has one or more metastatic lung nodules (not more than 5) Exclusion Criteria: * patient is pregnant or breast feeding . * patient with uncorrectable coagulopathy. * There are large blood vessels or important structures adjacent to lung lesion. * patient with more than five nodules

What they're measuring

Percentage of patients achieving adequacy of ablation

Timeframe: 24 hours post ablation

Percentage of patients achieving technical efficacy

Timeframe: 1 month after ablation

Local progression free survival

Timeframe: From the date of ablation up to six months

Trial details

NCT IDNCT04081181

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-05-13

Contact for this trial

Mostafa Ahmed Mamdouh El_Sharkawy, Prof.Dr

01223971443 Drmostafamri@yahoo.com

View on ClinicalTrials.gov More Lung Cancer trials